Abstract
Plasmalogens are unique vinyl ether glycerophospholipids that serve diverse structural roles in the membranes of cells and cell organelles. Additionally, the fatty acid substitutions at sn– 2 of the glycerol backbone are dynamically removed by lipases and replaced by acyltransferases. These fatty acid storage pools provide the free arachidonic acid and docosahexaenoic acid (DHA) involved in signal transduction cascades.
The biosynthesis of plasmalogens critically involves the generation of the ether lipid substitution at sn–1 of the glycerol backbone. This step only occurs in peroxisomes and is dysfunctional in genetic peroxisomal disorders and in several diseases of aging.
A number of approaches have been undertaken to augment plasmalogen levels in these clinical conditions. In this review we present the current status of alkylglycerol precursors that bypass the requirement of the peroxisomal compartment.
Keywords: Alkylglycerol, Ecomer, krill oil, DHA, plasmalogen, peroxisome.
Current Organic Chemistry
Title:Alkylglycerol Lipid Precursors: A Review of Therapeutic Strategies for Plasmalogen Replacement
Volume: 17 Issue: 8
Author(s): Paul L. Wood
Affiliation:
Keywords: Alkylglycerol, Ecomer, krill oil, DHA, plasmalogen, peroxisome.
Abstract: Plasmalogens are unique vinyl ether glycerophospholipids that serve diverse structural roles in the membranes of cells and cell organelles. Additionally, the fatty acid substitutions at sn– 2 of the glycerol backbone are dynamically removed by lipases and replaced by acyltransferases. These fatty acid storage pools provide the free arachidonic acid and docosahexaenoic acid (DHA) involved in signal transduction cascades.
The biosynthesis of plasmalogens critically involves the generation of the ether lipid substitution at sn–1 of the glycerol backbone. This step only occurs in peroxisomes and is dysfunctional in genetic peroxisomal disorders and in several diseases of aging.
A number of approaches have been undertaken to augment plasmalogen levels in these clinical conditions. In this review we present the current status of alkylglycerol precursors that bypass the requirement of the peroxisomal compartment.
Export Options
About this article
Cite this article as:
Wood Paul L., Alkylglycerol Lipid Precursors: A Review of Therapeutic Strategies for Plasmalogen Replacement, Current Organic Chemistry 2013; 17 (8) . https://dx.doi.org/10.2174/1385272811317080004
DOI https://dx.doi.org/10.2174/1385272811317080004 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
Call for Papers in Thematic Issues
Catalytic C-H bond activation as a tool for functionalization of heterocycles
The major topic is the functionalization of heterocycles through catalyzed C-H bond activation. The strategies based on C-H activation not only provide straightforward formation of C-C or C-X bonds but, more importantly, allow for the avoidance of pre-functionalization of one or two of the cross-coupling partners. The beneficial impact of ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Peripheral Benzodiazepine Receptor (PBR) New Insight in Cell Proliferation and Cell Differentiation Review
Current Clinical Pharmacology Subject Index To Volume 12
Current Pharmaceutical Design Valproic Acid Attenuates Neuronal Loss in the Brain of APP/PS1 Double Transgenic Alzheimer’s Disease Mice Model
Current Alzheimer Research Common Genetic Conditions of Ischemic Stroke to Keep in Mind
Current Molecular Medicine Vitamin E and All-Cause Mortality: A Meta-Analysis
Current Aging Science Nutraceuticals in Psychiatric Practice
Recent Patents on CNS Drug Discovery (Discontinued) Effects of Galantamine in Alzheimers Disease: Double-blind Withdrawal Studies Evaluating Sustained Versus Interrupted Treatment
Current Alzheimer Research Was Phenserine a Failure or Were Investigators Mislead by Methods?
Current Alzheimer Research A Cyclooxygenase-2 Inhibitor Reduces Vascular Wall Thickness and Ameliorates Cognitive Impairment in a Cerebral Small Vessel Diseases Rat Model
Current Alzheimer Research Neuroprotective Effects of Lutein in the Retina
Current Pharmaceutical Design Chronic Obstructive Pulmonary Disease and Asthma and the Risk of Mild Cognitive Impairment and Dementia: A Population Based CAIDE Study
Current Alzheimer Research Treating High Density Lipoprotein Cholesterol (HDL-C): Quantity Versus Quality
Current Pharmaceutical Design Impaired Translation of Spatial Representation in Young Onset Alzheimer’s Disease Patients
Current Alzheimer Research Aspirin Resistance in Cardiovascular Disease: Pathogenesis, Diagnosis and Clinical Impact
Current Pharmaceutical Design Machine Learning and Molecular Dynamics Based Insights into Mode of Actions of Insulin Degrading Enzyme Modulators
Combinatorial Chemistry & High Throughput Screening Anesthetic Neuroprotection: Antecedents and An Appraisal of Preclinical and Clinical Data Quality
Current Pharmaceutical Design A Novel Relationship for Schizophrenia, Bipolar and Major Depressive Disorder Part 6: A Hint from Chromosome 6 High Density Association Screen
Current Molecular Medicine Study of the Effects of L-tryptophane Nanoparticles on Motor Behavior in Alzheimer's Experimental Models
CNS & Neurological Disorders - Drug Targets Antioxidant Properties and Associated Mechanisms of Salicylates
Current Medicinal Chemistry Targeting Neuronal Nicotinic Receptors: a Path to New Therapies
Current Drug Targets - CNS & Neurological Disorders